Prostate Cancer
Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial
August 21, 2023
The impact of race on survival in metastatic prostate cancer: a systematic literature review.
August 21, 2023
Prostagram MRI in a Screening Population: PI-RADS or Likert?
August 21, 2023
Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer.
August 21, 2023
Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases.
August 21, 2023
Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity.
August 18, 2023
18F-DCFPyL PSMA-PET affects management of salvage radiotherapy for post-prostatectomy patients with biochemical failure: A matched cohort study.
August 18, 2023
SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor-induced growth suppression.
August 18, 2023
Unleashing the Power of Artificial Intelligence and Fusion Magnetic Resonance Imaging-Targeted Biopsy: Transforming Prostate Cancer Diagnosis.
August 18, 2023